Congress wants a single ALS patient to get a therapy never tested in humans. A family in Iowa believes the Food and Drug Administration will decide whether their only surviving daughter lives or dies, and they’ve been on a monthslong crusade to break through its bureaucracy. And they’re succeeding

Quick Read

Cancer drugs that speed onto the market based on encouraging preliminary studies often don’t show clear benefits when more careful follow-up trials are done, according to research published Tuesday

Quick Read

The military is constantly using technology to build better ships, warplanes, guns and armor. Shouldn’t it also use drugs to build better soldiers?

Quick Read

As regulatory professionals tasked with protecting research subjects, it’s important to understand the unique risks and benefits of social media use for research

Quick Read

Someone questioned his Japanese ancestry. So Kim, 34, took out his phone and consulted the 23andMe website. That’s when he discovered his ethnic identity had changed. The site that once told him he was about 40% Japanese now pegged that figure at 5%. He was, in an instant, fully Korean again

Quick Read

Our own bodies. We’ve sent people to space for decades — but we’re only beginning to learn what that means for their health

Quick Read

The FDA has taken an industry-friendly approach toward companies using unproven cell cocktails to treat people desperate for relief from aging or damaged joints

Quick Read

Imagine yourself stuck in the hospital. Would you rather your doctors be well-rested, with a limit on how many hours they can work? Or would you rather they work longer shifts, seeing you through the critical hours of your illness and with fewer handoffs of your care?

Quick Read